SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Saamya Biotech India informs about Outcome of Board Meeting

01 Jun 2015 Evaluate

Saamya Biotech India has informed that the Board of Directors of the Company at its meeting held on May 29, 2015, has adopted Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting Of Trading by Insiders (According to SEBI Prohibition of Insider Trading Regulations, 2015),adopted Secretarial Standards SS-1 and SS-2 and appointed Company Secretary for conducting the Secretarial Audit for the Financial Year 2014-15.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×